Salveo Capital

Managing Partners Michael C. Gruber and Jeffrey Howard lead the firm, with Principal Sean Doyle involved in day-to-day execution. Gruber brings experience from Cornerstone Angels and Taproot Ventures, while Howard's background includes running global prime services at Royal Bank of Scotland and heading Americas futures and options at Merrill Lynch. The team is supported by an advisory board that includes former Goldman Sachs Managing Director Thomas Mazarakis.

The firm's primary focus is on ancillary products and services that support the cannabis industry, including financial services and payments, ag-tech and grow systems, software and data analytics, bio-pharma and delivery systems, and business services. It also makes select investments into plant-touching businesses such as cultivation centers, dispensaries, and infused-product makers.

Yes. While the primary focus is on ancillary products and services, Salveo Capital explicitly states it makes select investments into businesses that touch the cannabis plant, including cultivation centers, dispensaries, and infused products. This dual approach reflects a strategy that covers both the industry's operating infrastructure and its core production and retail segments.

Salveo Capital sources deals through the combined networks of its managing partners, who have decades of experience in early-stage venture, institutional finance, and cannabis-specific advisory. The firm's advisory board, which includes an agricultural PhD with deep West Coast cultivation connections and a former Goldman Sachs fundamental investor, provides additional reach into distinct cannabis sub-sectors that few investment groups can cover simultaneously.

The firm is described as an early-stage investor targeting seed and startup-stage companies within the cannabis sector. It opportunistically considers opportunities across different stages but concentrates its capital at the earliest phases of company growth, where its institutional structuring and advisory support can shape long-term outcomes.

Salveo Capital operates as a private-equity firm, not a family office. While Managing Partner Michael Gruber previously founded investment organizations for high-net-worth investors and family offices, such as Cornerstone Angels, Salveo Capital functions as an asset management partnership making direct venture-capital-style investments into cannabis and ancillary companies.

No. The firm does not publicly disclose assets under management or total capital deployed. No external publication or filing has independently reported a verified AUM figure.